Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Seeka Limited Director's Dealing 2021

Feb 15, 2021

66268_rns_2021-02-15_faa003de-4d85-4db1-9a6f-6c607678ecfd.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [101 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:

Seeka Limited 15-Feb-21 7-Oct-20

Director or senior manager giving disclosure

Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

John Garland Burke Seeka Limited N/A Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Nature of the affected relevant interest(s):

Ordinary Shares

    1. J Burke is a director of J & D Burke Holdings Limited. J Burke is the registered holder of 10% of the shares in J & D Bruke Holdings Limited in his personal capacity and a registered holder of 80% of the shares in J & D Burke Holdings Limited jointly with others. As such J Burke has the power to control the exercise of 20% or more of the voting rights of J & D Burke Holdings Limited, resulting in J Burke having a relevant interest in the Ordinary Shares of Seeka Limited held by J & D Burke Holdings Limited. 2) Seeka Share Trustee Limited holds Ordinary Shares for and on behalf of J & D Burke Holdings Limited. For the reasons stated in 1), J Burke also has a relevant interest in the Ordinary Shares of Seeka Limited held by Seeka Share Trustee Limited for and on behalf of J & D Burke Holdings Limited.
    1. Registered holder of Ordinary Shares held by Martyn Timothy Brick, Christopher James McFadden and John Garland Burke as trustees of the Rockeby Trust.

For that relevant interest-

    1. 90,441 Ordinary Shares

Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:

    1. 4,365 Ordinary Shares
    1. 83,000 Ordinary Shares
    1. 92,584 Ordinary Shares
    1. 4,365 Ordinary Shares 3) 83,000 Ordinary Shares NA 1) J & D Burke Holdings Limited 2) Seeka Share Trustee Limited for and on behalf of J & D Burke Holdings Limited 3) Martyn Timothy Brick, Christopher James McFadden and John Garland Burke as trustees of the Rockeby Trust.

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative:

NA NA NA NA NA NA NA NA NA

If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

NA

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

1 Transaction 27 January 2021 Allotment pursuant to Seeka Limited's Dividend Reinvestment Plan NA $10,098.67 (2,143 Ordinary Shares at $4.7124 each) 2,143

No NA NA

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s):

For a derivative relevant interest,- Type of derivative:

NA NA NA NA NA

Details of derivative,-

Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): NA
A statement as to whether the derivative is cash settled or physically settled: NA
Maturity date of the derivative (if any): NA
Expiry date of the derivative (if any): NA
The price's specified terms (if any): NA
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying NA
financialproducts:
For that derivative relevant interest,- NA
Parties to the derivative: NA
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: NA

Certification

Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer: J G Burke
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer: S McKinstry
Date of signature: 15-Feb-21
Name and title of authorisedperson: S McKinstry- CFO